Abstract. We examined whether seminiferous tubular function develops normally after discontinuation of long-term gonadal suppression in premature male rats. Wistar male rats 4 weeks old were subjected to the injection of gonadotropin-releasing hormone (Gn-RH) agonist or normal saline solution as control for 12 weeks. The rats were sacrificed 0 and 6 weeks after discontinuation of the treatment. Histological examinations of the seminiferous tubules immediately after cessation of the Gn-RH agonist treatment demonstrated a stage-related change in specific germ cells. Seminiferous tubules of Gn-RH agonisttreated rats were narrow and irregular in shape, and contained significantly fewer spermatids and pachytene spermatocytes at stages VII to XIV than those in controls. A complete development of spermatogenesis was histologically observed 6 weeks after cessation of the treatment. Leydig cells became atrophic without any reduction in cell number immediately after the treatment, but Leydig cells grew rapidly and were similar in appearance to those in control rats 6 weeks after cessation of the treatment. Serum testosterone concentrations were noticeably suppressed immediately after cessation of the treatment (P<0.01 vs. control) and reached a similar level to those of controls 6 weeks after the cessation. Testes weights were significantly lower in Gn-RH agonist-treated rats than in control rats and had not fully developed 6 weeks after cessation of the treatment (P<0.01 vs. control). These results suggest that the testicular function develops normally after cessation of the long-term gonadal suppression in premature rats, although the increase in testicular weight may be slightly influenced.
PATIENTS with precocious puberty have been generally treated with long-acting gonadotropinreleasing hormone (Gn-RH) agonistic analog in clinics [1] [2] [3] [4] . Jay et. al. [5] reported that gonadal function normally developed after cessation of Gn-RH agonist therapy in patients with central
Received: January 23, 1997 Accepted: May 16, 1997 Correspondence to: Dr. Kenji OHYAMA, Department of Pediatrics, Yamanashi Medical University, 1110 Shimogato, Tamaho-cho, Nakakoma-gun, Yamanashi 409-38, Japan precocious puberty. These patients were treated during the prepubertal age and discontinued the treatment at the early pubertal age. Recently normal short children were treated with Gn-RH agonist for prolongation of GH therapy [6, 7] . These patients were treated for several years from early to late pubertal age, since they had no sexual precocity.
Their pubertal development started at the late pubertal age after cessation of the Gn-RH agonist therapy. It is still not known whether gonadal tissues normally mature after cessation of the therapy in the short normal children. Several researchers reported that the suppression of gonadal function by Gn-RH agonist treatment was completely reversible in adult male and female rats [8, 9] . There are, however, insufficient data on the sexual development after cessation of Gn-RH agonist treatment when the gonadal function was suppressed before the natural onset of puberty by the treatment.
It Germ cells per seminiferous tubule were counted at stages 1-VI, VII-VIII, IX-XI and XII-XIV [10] . Fifteen tubules in each stage per testis were counted. The cell counts were corrected with the Abercrombie formula [11] . The intra-and interassay coefficients of variation in testosterone radioimmunoassay were 2.6% and 8.2%, respectively.
The minimum limit of sensitivity was 50 pg/m1.
Data were analyzed with one-way analysis of variance and Tukey's test to determine significant differences at the 5% level.
Methods

Results
Wistar male rats aged four weeks were housed at 22 °C on a 12-h light, 12-h dark cycle. All animals were fed a pelleted diet ad libitum and given free access to water. The animals were divided into two Groups of 12 rats and were subjected to the injection of Gn-RH agonist (D-Leu6-[des-Glylo-NH2]-Gn-RH ethylamide acetate; sustained release leuprorelin acetate, Takeda Pharmaceutical) or normal saline solution as control for the following periods. Six hundred ,ug/body weight (kg) of Gn-RH agonist were subcutaneously administered every two weeks for 12 weeks (from 4 weeks old to 16 weeks old). Six rats were sacrificed at 0 or 6 weeks after cessation of Gn-RH agonist treatment.
Serum testosterone concentrations and wet weights
In 4-week-old rats (before treatment), serum testosterone concentrations were below 10 ng/dl, and wet weights of testes were 0.37 ± 0.02 g (mean ± SEM, n=6). The serum testosterone concentrations and testes weights after Gn-RH agonist treatment are shown in Table 1 . In Gn-RH agonist-treated rats, serum testosterone concentrations were niticeably suppressed immediately after cessation of the treatment (P<0.01 vs. control), but they reached a similar level to those of control rats at 6 weeks after cessation of the treatment.
Testes weights were significantly lower in Gn-RH agonist-treated rats than in control rats and had not fully developed 6 weeks after cessation Table 1 . Testis weight and serum testosterone concentration in rats treated with Gn-RH agonist for 12-week of the Gn-RH agonist treatment (P<0.01 vs. control).
Histological examinations of the seminiferous tubules after the Gn-RH agonist treatment demonstrated stage-related changes in specific germ cells. Figure 1 shows light micrographs of seminiferous tubules at stage VII. The seminiferous tubules of Gn-RH agonist-treated rats were narrow and irregular in shape compared to non-treated rats ( Fig.1 a, b) . In Gn-RH agonist-treated rats, there were noticeably fewer spermatids, especially elongated spermatids, compared to those in controls. Six weeks after cessation of the treatment, the shape and size of the seminiferous tubules were similar to the controls, and complete development of spermatogenesis was observed ( Fig. 1 c, d) .
The quantitative analyses of spermatogenesis are shown in Table 2 As shown in Fig. 2 , immediately after cessation 
Discussion
Agonistic analogs of Gn-RH down-regulate the secretion of pituitary gonadotropins and circulating hormones fall to prepubertal levels [12] [13] [14] [15] . Recent indications for the possible use of Gn-RH agonist for short normal children [6, 7, 16] growth and testosterone secretion.
In adult rats, the testicular weight, which was 14 to 27% of the control at the end of treatment [8, 9] , had fully recovered by 6 to 8 weeks posttreatment. Nevertheless, in our study, when the gonadal function was suppressed before the natural onset of puberty, the testicular weights were significantly reduced even 6 weeks after cessation of the treatment, although the diameter of the seminif erous tubules in the treated-rats appeared to be similar to that in the control.
These 
